ISS Lab Selected Eight Startups for Accelerator Cohort
Early-stage firms will receive up to $750,000 to advance space-based research and dual-use manufacturing.
Updated on Sept. 30, 2026 in Startups
Live Poll
Should private space startups align their technology development with federal government research priorities?
The ISS National Laboratory has selected eight startups for the second cohort of its Orbital Edge Accelerator. Participants gain access to low Earth orbit for technology development and funding between $500,000 and $750,000.
Why it matters
The program helps private companies scale technological advancements in space-based biology and satellite operations. It provides a structured path for businesses to commercialize research and development in an emerging extraterrestrial economy.
Selected companies receive funding between $500,000 and $750,000, distributed in two equal installments. One project will also be eligible for the Technology in Space Prize, which carries a maximum value of $100,000.
The players
ISS National Laboratory
An organization tasked with maximizing the utility of the International Space Station for research and development.
Draper Associates
A venture capital firm focused on early-stage technology investments.
The details
The accelerator is divided into two operational tracks: the Sentinel Track for satellite technology and the Disrupt Track for biomanufacturing and nanomedicines. Beyond direct funding, startups receive specialized business development training, mentorship, and investor engagement. The lab manages the integration of these projects into low Earth orbit, providing a logistical pathway for startups to transition from terrestrial prototyping to orbital deployment.
Timeline
The Orbital Edge Accelerator launched with six startups in 2025.
The program selected its second cohort of eight startups in 2026.
Participating startups will present their projects at a demo day in San Francisco in December 2026.
Market Landscape
The accelerator's expansion into dual-use applications and in-space manufacturing follows the strategic directive set by the 2025 memo on R&D priorities. This activity reflects an industry trend toward deeper integration between private startup capital and national aerospace infrastructure.
Operators in deep-tech and manufacturing should monitor the demo day in December 2026 as a signal for emerging commercial capabilities in orbit. Companies seeking to leverage space-based R&D should evaluate the feasibility of dual-use applications to align with government-backed funding trends.
The takeaway
The growth of the Orbital Edge Accelerator confirms that in-space manufacturing and bio-research are moving from niche academic pursuits to viable commercial sectors. Review your company's long-term R&D roadmap to determine if space-based experimentation offers a scalable competitive advantage.
Further reading
For more on the current climate for emerging technology firms, visit our Startups section.
Source note: This article includes information reported by Research & Development World.
Live Poll
Should private space startups align their technology development with federal government research priorities?
